GlassScriptPhysician profile
Laura Greco
NPI 1679951388
$2,549.81
in general payments reported to CMS, 2019-2025
7 companies · $225 in 2025
The $225 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $33.92 · 2021: $226 · 2022: $1,784 · 2023: $106 · 2024: $175 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $505.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,058.00 | 2021-2023 | Da Vinci Surgical System |
| Integra Lifesciences Corporation | $168.35 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Davol INC. | $124.90 | 2024 | Arista Ah Flexitip |
| Medtronic, INC. | $98.77 | 2021-2025 | Signia |
| Baxter Healthcare | $45.10 | 2023-2024 | Floseal, Perclot |
| Baudax Bio INC. | $33.92 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.77 | 2024 | Gattex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Greco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.